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canonical Wnt signaling) is able to rescue
the axis truncation phenotype of Cdx
mutants. However, when activated Lef1
is overexpressed in wild-type embryos,
no increase in axis elongation is observed
as one might have expected, thus these
feedback loops cannot account for the
whole story.
The present work also challenges the
posterior prevalence model for Hox gene
function, which is commonly thought of
being an evolutionarily conserved prop-
erty of Hox genes during axial patterning
(Duboule and Morata, 1994). Posterior
prevalence postulates that 50 (posterior)
Hox genes are functionally dominant over
30 (anterior) genes. However, when Young
et al. (2009) overexpress anterior Hox
genes (e.g., Hoxb8) in transgenic animals
that also overexpress Hoxb13 (and which
by itself leads to axis truncation) they
observe a rescue of the axis truncation
phenotype. It appears therefore, that
collinear activation of Hox genes is by it-
self not sufficient to explain how the elon-
gation process is halted; it may in addition
be necessary to actively clear anterior
Hox gene activities from the tail. Alterna-
tively, a certain ratio of expression of the
posterior Hox genes versus more anterior
genes might be required to suppress axis
elongation. Here, the detailed study of
Young et al. (2009) provides a possible
explanation: since overexpression of
Hoxb13 is able to downregulate Wnt3a,
this could indicate that with the onset of
posterior group Hox genes, the positive
feedback loop betweenWnt3a-Cdx-trunk
Hoxgenesbecomes inactivated (since the
initiatingWnt-signaling is being repressed
by posterior Hox genes). Thus, the study
by Young et al. (2009) suggests that
collinear Hox activation combined with
genetic feedback loops are controlling
the axis elongation—and termination—
process.
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The identities of cells, determined by differential gene expression, are heritably maintained by the antago-
nistic functions of Polycomb group (PcG) and Trithorax group proteins. Two recent papers shed new light
on tumor suppressive functions of PcG by reporting direct silencing of the Notch and JAK/STAT signaling
pathways in Drosophila melanogaster.Since its discovery by Thomas Hunt
Morgan in 1917, the Notch gene has
attracted the attention of numerous
researchers. Notch is not only part of one
of the best-conserved signal transduction
pathways in metazoan development but
is also a potent oncogene when deregu-
lated.Molecular identification of the Notch
transmembrane receptor was followed by
the unraveling of an apparently simple and
direct signal transduction mechanism:440 Developmental Cell 17, October 20, 200Activation of Notch by the binding of its
ligands Delta or Serrate/Jagged results
in the proteolysis of the transmembrane
receptor and the release of the intracel-
lular domain, which engages in transcrip-
tional regulation. Quite a number of inter-
acting components have been identified
in the meanwhile, however, pinpointing
toacomplicated circuitry regulatingmatu-
ration, endocytosis and degradation of
the receptor and its ligands.9 ª2009 Elsevier Inc.Early studies with Drosophila PcG
mutants revealed a tumor suppressor
capabilityof this classofepigenetic regula-
tors, although, the phenotypic features
observed during imaginal disc develop-
ment were quite diverse and complicated
to interpret (Beuchle et al., 2001; Janody
et al., 2004). Recently, a study addressing
the mechanisms underlying these obser-
vations uncovered a dynamic modulation
of cell-cycle regulator genes by the PcG
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Figure 1. PcG-Mediated Control of the Notch Pathway and Tumor Formation in Drosophila melanogaster
(A) Besides classical targets like the HOX gene clusters, the PRC1 complex (depicted here with its four core components) represses the unpaired (upd), eyegone
(eyg), Serrate (Ser), and Notch genes.
(B) Inactivation of the PRC1 complex results in expression of Upd, Notch, and Ser. Consequently, the Notch and JAK-STAT signaling pathways are activated,
contributing through their respective target genes to tumor formation.
(C) Taking into account the results of other studies as well, an extended model emerges. Activation of Notch results in expression of Eyg, which itself induces
expression of a ligand for the JAK-STAT pathway (Upd). Both Notch and JAK/STAT signaling are oncogenic, but it remains unclear whether the derepression
of other PRC1-silenced genes (such as upd, eyg, Ser, and additional cell cycle regulators) contributes to tumor formation. Cell type-specific regulation by the
JAK/STAT pathwaymay up-regulateDelta and/or repress Ser in this model. Furthermore, whereas it is apparent that PRC1 is involved in repression of HOX genes
in almost all cell types, the tumor-suppressor activities of the four depicted PRC1 core members are very diverse, with only Ph showing consistent phenotypes.studies.(Oktaba et al., 2008). Posterior sex combs
and Supressor of zeste 2 (Psc-Su(z)2),
Polyhomeotic (Ph), Sex combs extra (Sce),
and Polycomb (Pc), all constituents of the
PRC1 complex, are required for develop-
ment and patterning of the wing imaginal
disc, but only Ph and Psc-Su(z)2 act as
tumor suppressors in this context, con-
firming the previously noted phenotypic
diversity. The study from Classen et al.
(2009) in a recent issue of Nature Genetics
extended these findings and identified
PRC1 components as tumor suppressors
in the development of the eye imaginal
disc. In their tests, Pc and Sce behave as
tumor suppressors, whereas Psc-Su(z)2
mutant cells die and cause overgrowth of
the surrounding wild-type tissue. The
authors assayed the contribution of differ-
ent signaling pathways to the observed
tumor suppressor activity and identified
members of the unpaired gene family, en-
coding ligands for the JAK-STAT pathway
as direct targets for PRC1-mediated
repression. Mutations in any of the PRC1
components resulted in the increased
expression of Unpaired and the subse-
quent activation of the JAK-STAT onco-
genic pathway. Conversely, inhibition of
JAK-STAT signaling suppressed PcG-
induced tumor formation. Since the Paxtranscription factor Eyegone mediates
the growth-promoting function of Notch
in the eyedisc through the direct activation
of unpaired (Dominguez et al., 2004), one
might have expected unpaired derepres-
sion to be mediated in parallel by Notch/
Eyegone-mediated activation of the gene.
However, Classen et al. (2009) did not
observe consistent upregulation of the
Notchpathway in theirassays.Ontheother
hand, in a second paper published in the
same issue of Nature Genetics, Martinez
et al. (2009) identified the Notch pathway
as the major signaling component to
tumor growth in phmutant eye disc tissue.
They found that Notch and Serrate but
not Delta are direct targets for Ph/PRC1-
mediated repression. Moreover, domi-
nant-negative Notch and RNAi-based
approaches both indicated that blocking
Notch pathway activity reduces the over-
growth of ph tumor tissue. It remains to
be seen whether the difference in Notch
signaling activity observed by these two
groups rests on the complexities of differ-
ential PRC1 functions discussed above or
simply on the issue of assay sensitivity,
as Martinez et al. (2009) isolated mutant
ph cells from the surrounding wild-type
tissue prior to their gene-expressionDevelopmental CellMartinez et al. (2009) suggest an intrigu-
ing model for PRC1-mediated control of
theNotch signaling pathway and its contri-
butions to tumor formation in the respec-
tive PcG mutants (Figures 1A and 1B).
However, as frequently encountered in the
field of Notch research, apparently minor
inconsistencies in phenotypes reveal a
seemingly overwhelming complexity in the
regulation of this pathway. For instance,
Martinez et al. (2009) observed an upregu-
lation of Serrate in ph tumors and sug-
gested that Ph specifically regulates
Notch-Ser signaling; however, they also
noted that theactivationofadirect reporter
for Notch signaling wasmost prominent in
mutant cells adjacent to wild-type cells.
This latter observation indicates that the
signal-receiving cells—the ones express-
ing the reporter—in this case are mutant
cells. It also suggests that those cells
may activate the reporter more efficiently
when surrounded by wild-type cells than
bymutant cells. Thus, mutant cells appear
to present ligand less effectively than their
wild-type counterparts. Consequently,
the overexpression of Serrate within the
tumors would not play any or only a minor
role. Furthermore, Eyegone expression
showedavery similar pattern,whichwould
suggest that its expression in the tumors17, October 20, 2009 ª2009 Elsevier Inc. 441
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Previewsis strictly regulated by Notch. Therefore,
the loss of PRC1 binding to the eyegone
gene would rather be a consequence
than a cause. The same would be true for
the unpaired gene. This notion goes along
with the published observation that over-
expression of an activated form of Notch
results in JAK-STAT-dependent tumor
formation (Reynolds-Kenneally and Mlod-
zik,2005).This implies thatactivatedNotch
can fully override the repressive PRC1
function. Besides the interesting problem
of how Notch is capable to do so, this rai-
ses the question why these genes would
be targets for PcG-mediated silencing at
all. One possible explanationmight be that
repression by the PcG raises the threshold
Notch has to overcome to activate certain
genes and that even in the absence of
this repression another basal repression
mechanism exists.
When taking into account two other
very recent papers about JAK-STAT and
Notch signaling, themodel is complicated
even further. In a recent issue of Cell it
was reported that upregulation of Delta
expression by the JAK-STAT pathway442 Developmental Cell 17, October 20, 2009induces a concomitant increase in Notch
signaling during regeneration and homeo-
stasis in the Drosophila midgut (Jiang
et al., 2009). In contrast, microarray
studies as well as analyses with different
mutants in the eye disc revealed a repres-
sion of Notch signaling by activated
JAK-STAT (Flaherty et al., 2009). This
repression depends on the position of
the mutant cells with respect to tissue
polarity but in any case stands in contrast
to the above-mentioned findings. Given
the diversity in phenotypes obtained with
the different PRC1 mutants, the stage
and tissue-specific effects of PcG on
cell-cycle genes and the limited overlaps
in DNA binding profiles, these results
suggest complicated intertwined mecha-
nisms connecting epigenetic gene con-
trol to Notch and JAK-STAT signaling
(Figure 1C). It becomes increasingly
evident that cell type-specific compo-
nents strictly decide upon the path into
the cancer trap. Future studies, taking
into account these specificities in their
experimental setup, will have to clarify
these new findings and eventually deter-ª2009 Elsevier Inc.mine also their contributions to human
cancers.
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